RF | CS | SS | ||||
---|---|---|---|---|---|---|
Odds ratio (CI) | p | Odds ratio (CI) | p | Odds ratio (CI) | p | |
Agea | 1.07 (1.01–1.12) | 0.01 | 1.08 (1.02–1.13) | 0.01 | 1.04 (0.96–1.13) | 0.30 |
Yeara | 0.65 (0.45–0.93) | 0.02 | 0.88 (0.59–1.31) | 0.51 | 2.28 (0.62–8.42) | 0.22 |
< 20 patients/yearsa | 4.04 (1.27–12.86) | 0.02 | 2.07 (0.61–7.1) | 0.25 | NA | NA |
SAPS IIb | 1 (0.97–1.03) | 0.93 | 1.03 (1–1.06) | 0.03 | 0.99 (0.94–1.04) | 0.71 |
pH pre-ECMOc | 0.55 (0.01–50.19) | 0.79 | 0.22 (0–0.66) | 0.03 | 0.21 (0–1118) | 0.72 |
Base excess pre-ECMOd | 0.94 (0,86–1.03) | 0.17 | 0.89 (0.82–0.97) | 0.01 | 1.04 (0.88–1.22) | 0.69 |
Lactate pre-ECMOe | 1.02 (0.99–1.05) | 0.27 | 1.03 (1.01–1.05) | < 0.01 | 0.99 (0.95–1.02) | 0.34 |
Hyperlipidaemiaf | 2.77 (0.26–29.72) | 0.40 | 0.07 (0.01–0.64) | 0.02 | 0.37 (0.04–3.4) | 0.38 |